Development of an international glossary for clinical guidelines collaboration
Copyright © 2023 Elsevier Inc. All rights reserved..
OBJECTIVES: Clinical practice guidelines (CPGs) are often created through collaboration among organizations. The use of inconsistent terminology may cause poor communication and delays. This study aimed to develop a glossary of terms related to collaboration in guideline development.
STUDY DESIGN AND SETTING: A literature review of collaborative guidelines was performed to develop an initial list of terms related to guideline collaboration. The list of terms was presented to the members of the Guideline International Network Guidelines Collaboration Working Group, who provided presumptive definitions for each term and proposed additional terms to be included. The revised list was subsequently reviewed by an international, multidisciplinary panel of expert stakeholders. Recommendations received during this pre-Delphi review were implemented to augment an initial draft glossary. The glossary was then critically evaluated and refined through two rounds of Delphi surveys and a virtual consensus meeting with all panel members as Delphi participants.
RESULTS: Forty-nine experts participated in the pre-Delphi survey, and 44 participated in the two-round Delphi process. Consensus was reached for 37 terms and definitions.
CONCLUSION: Uptake and utilization of this guideline collaboration glossary by key organizations and stakeholder groups may facilitate collaboration among guideline-producing organizations by improving communication, minimizing conflicts, and increasing guideline development efficiency.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:158 |
|---|---|
| Enthalten in: |
Journal of clinical epidemiology - 158(2023) vom: 12. Juni, Seite 84-91 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Christensen, Rachel E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical |
|---|
| Anmerkungen: |
Date Completed 17.07.2023 Date Revised 05.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jclinepi.2023.03.026 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355240491 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355240491 | ||
| 003 | DE-627 | ||
| 005 | 20240305231859.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jclinepi.2023.03.026 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1317.xml |
| 035 | |a (DE-627)NLM355240491 | ||
| 035 | |a (NLM)37019344 | ||
| 035 | |a (PII)S0895-4356(23)00077-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Christensen, Rachel E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Development of an international glossary for clinical guidelines collaboration |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.07.2023 | ||
| 500 | |a Date Revised 05.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
| 520 | |a OBJECTIVES: Clinical practice guidelines (CPGs) are often created through collaboration among organizations. The use of inconsistent terminology may cause poor communication and delays. This study aimed to develop a glossary of terms related to collaboration in guideline development | ||
| 520 | |a STUDY DESIGN AND SETTING: A literature review of collaborative guidelines was performed to develop an initial list of terms related to guideline collaboration. The list of terms was presented to the members of the Guideline International Network Guidelines Collaboration Working Group, who provided presumptive definitions for each term and proposed additional terms to be included. The revised list was subsequently reviewed by an international, multidisciplinary panel of expert stakeholders. Recommendations received during this pre-Delphi review were implemented to augment an initial draft glossary. The glossary was then critically evaluated and refined through two rounds of Delphi surveys and a virtual consensus meeting with all panel members as Delphi participants | ||
| 520 | |a RESULTS: Forty-nine experts participated in the pre-Delphi survey, and 44 participated in the two-round Delphi process. Consensus was reached for 37 terms and definitions | ||
| 520 | |a CONCLUSION: Uptake and utilization of this guideline collaboration glossary by key organizations and stakeholder groups may facilitate collaboration among guideline-producing organizations by improving communication, minimizing conflicts, and increasing guideline development efficiency | ||
| 650 | 4 | |a Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Clinical | |
| 650 | 4 | |a Collaboration | |
| 650 | 4 | |a Delphi | |
| 650 | 4 | |a Development | |
| 650 | 4 | |a Glossary | |
| 650 | 4 | |a Guideline | |
| 650 | 4 | |a International | |
| 650 | 4 | |a Practice | |
| 650 | 4 | |a Validation | |
| 700 | 1 | |a Yi, Michael D |e verfasserin |4 aut | |
| 700 | 1 | |a Kang, Bianca Y |e verfasserin |4 aut | |
| 700 | 1 | |a Ibrahim, Sarah A |e verfasserin |4 aut | |
| 700 | 1 | |a Anvery, Noor |e verfasserin |4 aut | |
| 700 | 1 | |a Dirr, McKenzie |e verfasserin |4 aut | |
| 700 | 1 | |a Adams, Stephanie |e verfasserin |4 aut | |
| 700 | 1 | |a Amer, Yasser S |e verfasserin |4 aut | |
| 700 | 1 | |a Bisdorff, Alexandre |e verfasserin |4 aut | |
| 700 | 1 | |a Bradfield, Lisa |e verfasserin |4 aut | |
| 700 | 1 | |a Brown, Steve |e verfasserin |4 aut | |
| 700 | 1 | |a Earley, Amy |e verfasserin |4 aut | |
| 700 | 1 | |a Fatheree, Lisa A |e verfasserin |4 aut | |
| 700 | 1 | |a Fayoux, Pierre |e verfasserin |4 aut | |
| 700 | 1 | |a Getchius, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Ginex, Pamela |e verfasserin |4 aut | |
| 700 | 1 | |a Graham, Amanda |e verfasserin |4 aut | |
| 700 | 1 | |a Green, Courtney R |e verfasserin |4 aut | |
| 700 | 1 | |a Gresele, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Hanson, Helen |e verfasserin |4 aut | |
| 700 | 1 | |a Haynes, Norrisa |e verfasserin |4 aut | |
| 700 | 1 | |a Hegedüs, Laszlo |e verfasserin |4 aut | |
| 700 | 1 | |a Hussein, Heba |e verfasserin |4 aut | |
| 700 | 1 | |a Jakhmola, Priya |e verfasserin |4 aut | |
| 700 | 1 | |a Kantorova, Lucia |e verfasserin |4 aut | |
| 700 | 1 | |a Krishnasamy, Rathika |e verfasserin |4 aut | |
| 700 | 1 | |a Krist, Alex |e verfasserin |4 aut | |
| 700 | 1 | |a Landry, Gregory |e verfasserin |4 aut | |
| 700 | 1 | |a Lease, Erika D |e verfasserin |4 aut | |
| 700 | 1 | |a Ley, Luis |e verfasserin |4 aut | |
| 700 | 1 | |a Marsden, Gemma |e verfasserin |4 aut | |
| 700 | 1 | |a Meek, Tim |e verfasserin |4 aut | |
| 700 | 1 | |a Meremikwu, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Moga, Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Mokrane, Saphia |e verfasserin |4 aut | |
| 700 | 1 | |a Mujoomdar, Amol |e verfasserin |4 aut | |
| 700 | 1 | |a Newton, Skye |e verfasserin |4 aut | |
| 700 | 1 | |a O'Flynn, Norma |e verfasserin |4 aut | |
| 700 | 1 | |a Perkins, Gavin D |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Emma-Jane |e verfasserin |4 aut | |
| 700 | 1 | |a Prematunge, Chatura |e verfasserin |4 aut | |
| 700 | 1 | |a Rychert, Jenna |e verfasserin |4 aut | |
| 700 | 1 | |a Saraco, Mindy |e verfasserin |4 aut | |
| 700 | 1 | |a Schünemann, Holger J |e verfasserin |4 aut | |
| 700 | 1 | |a Senerth, Emily |e verfasserin |4 aut | |
| 700 | 1 | |a Sinclair, Alan |e verfasserin |4 aut | |
| 700 | 1 | |a Shwayder, James |e verfasserin |4 aut | |
| 700 | 1 | |a Stec, Carla |e verfasserin |4 aut | |
| 700 | 1 | |a Tanni, Suzana |e verfasserin |4 aut | |
| 700 | 1 | |a Taske, Nichole |e verfasserin |4 aut | |
| 700 | 1 | |a Temple-Smolkin, Robyn L |e verfasserin |4 aut | |
| 700 | 1 | |a Thomas, Louise |e verfasserin |4 aut | |
| 700 | 1 | |a Thomas, Sherene |e verfasserin |4 aut | |
| 700 | 1 | |a Tonnessen, Britt |e verfasserin |4 aut | |
| 700 | 1 | |a Turner, Amy S |e verfasserin |4 aut | |
| 700 | 1 | |a Van Dam, Anne |e verfasserin |4 aut | |
| 700 | 1 | |a van Doormaal, Mitchell |e verfasserin |4 aut | |
| 700 | 1 | |a Wan, Yung Liang |e verfasserin |4 aut | |
| 700 | 1 | |a Ventura, Christina B |e verfasserin |4 aut | |
| 700 | 1 | |a McFarlane, Emma |e verfasserin |4 aut | |
| 700 | 1 | |a Morgan, Rebecca L |e verfasserin |4 aut | |
| 700 | 1 | |a Ogunremi, Toju |e verfasserin |4 aut | |
| 700 | 1 | |a Alam, Murad |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical epidemiology |d 1991 |g 158(2023) vom: 12. Juni, Seite 84-91 |w (DE-627)NLM012614815 |x 1878-5921 |7 nnns |
| 773 | 1 | 8 | |g volume:158 |g year:2023 |g day:12 |g month:06 |g pages:84-91 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jclinepi.2023.03.026 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 158 |j 2023 |b 12 |c 06 |h 84-91 | ||